Companies: 10,795·Total market cap: $144.5T
AxoGen, Inc.

AxoGen, Inc.

AXGNNASDAQHealthcare● Active
$41.46
$-1.34(-3.13%)
Market Cap$2.2B
P/E Ratio
52W High$45.83
52W Low$9.22
Overview

AxoGen, Inc. (AXGN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

axgn · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 19 Wall Street analysts in the past 3 months

SellBuy

Buy

19 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
16
Hold
3
Sell
0
Strong Sell
0
Total: 19 · Buy rate: 84.2%

12-Month Price Target

High

$50.00

Consensus

$47.00

+13.4% upside

Low

$40.00

Median: $49 · Last Close: $41.46

The AxoGen, Inc. (AXGN) analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month AXGN price target is $47.00, representing +13.4% upside from the current price of $41.46.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $47 (13.4%)

Consensus Target

$47.00

13.4% upside

High Target

$50

20.6%

Low Target

$40

-3.5%

Current Price

$41.46

as of today

Based on analyst price targets, the AXGN stock price prediction for the next 12 months ranges from $40 to $50. The consensus AXGN price forecast of $47.00 implies 13.4% upside from the current price of $41.46.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$41.780.78%

1-day model range: $41.59–$41.97. Peak: $41.97 (+0.78%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$70+67.8%
2028$98+136.1%
2029$122+193.7%
2030$140+236.7%
2031+266.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

86%7%7%
12Buy
1Neutral
1Sell
RSI (14)48.0Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · AXGN · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$41.35BUY
MA 10$40.67BUY
MA 20$41.01BUY
MA 50$38.74BUY
MA 100$35.68BUY
MA 200$29.30BUY
Current $AXGN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$41.46SELL
EMA 10$41.15BUY
EMA 20$40.87BUY
EMA 50$39.00BUY
EMA 100$35.86BUY
EMA 200$30.74BUY
Current $AXGN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-04-29
Maintains
BuyBuy
Citizens2026-04-29
Maintains
Market OutperformMarket Outperform
Canaccord Genuity2026-04-29
Maintains
BuyBuy
Wells Fargo2026-04-29
Maintains
OverweightOverweight
Lake Street2026-04-23
Maintains
BuyBuy
Canaccord Genuity2026-03-30
Maintains
BuyBuy
Citizens2026-02-24
Maintains
Market OutperformMarket Outperform
HC Wainwright & Co.2025-12-05
Maintains
BuyBuy
Canaccord Genuity2025-12-05
Maintains
BuyBuy
Jefferies2025-12-04
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on AxoGen, Inc. (AXGN) stock. Of the recent 62 rating actions, 3 were upgrades and 5 were downgrades. 19 analysts currently cover AXGN.

Analyst Recommendation Trends

Buy ratings15↑ +4
Hold ratings00
Sell ratings00

AXGN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 5 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$271M

↓ 28.4% YoY

Revenue Next Year

$319M

↑ 17.6% YoY

EPS This Year

$0.50

EPS Next Year

$0.72

↑ 44.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AXGN EPS of $0.50 for the current fiscal year, based on estimates from 5 analysts. The AXGN revenue forecast is $271M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AXGN stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AXGN price target is $47.00 (+13.4% upside), with an analyst consensus of Buy.

The AXGN short-term stock prediction for tomorrow is $41.78 (+0.78%). The AXGN stock price prediction for 2027 estimates an average of $70. The AXGN stock prediction for 2030 projects a range of $133–$147.

AxoGen, Inc. trades on NASDAQ under the ticker AXGN. The AXGN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 84% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AXGN forecast · 8 questions

According to 19 Wall Street analysts, the average 12-month AXGN price target is $47.00, with a high forecast of $50.00 and a low of $40.00. The median price target is shown in the chart above when available. This implies +13.4% potential upside from the current price of $41.46.

AXGN price targetWhat is AXGN price targetAXGN analyst price targetAXGN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.